•Angiotech's corporate partner, Boston Scientific, reports two-year SYNTAX data showing comparable safety outcomes for complex patients treated with Taxus(R) Express(R) stents and bypass surgery PR Newswire(Wed 3:30pm)
ANPI in at 1.67,, got it right this time , slap me ,,MERC go boom again, and TRID still holding.GBE stating to show signs of life still setting on it too.PADDY